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Introduction and objectives: To investigate the effects of ethanol, diabetes mellitus and the combination 
of both on mouse fetuses. Methods: We used 24 female Swiss mice, dividing them into four groups 
of 6 each: control (C), ethanol (E), diabetes (D) (blood glucose > 200 mg/dL) and diabetes + ethanol 
(DE). Diabetes was induced by alloxan (40 mg/kg) on day 7 of pregnancy. Groups E and DE received 
4 g/kg of 25% v/v ethanol intraperitoneally, whereas groups C and D received saline. On day 18, all 
fetuses were harvested. Results: In group DE the following anomalies were found: exencephaly, situs 
inversus totalis, situs inversus partialis, eyelid skin tag and one animal from group E had pulmonary artery 
hypoplasia. Ethanol administration partially reverted diabetes-fetal resorption caused by diabetes, yet it 
induced late fetal death. Both diabetes and ethanol reduced placental diameter and increased its weight. 
Ethanol had more effect on fetal length in males than in females, however, such bias was not found for 
diabetes. Ethanol prevented diabetes-induced tail shortening in both genders. Conclusions: These results 
show that, although ethanol might improve energy metabolism in early gestation, it causes cell damage 
that leads to cardiovascular, limb and neural tube defects, late fetal death and reduced placental size.
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resumo
Introdução e objetivos: Investigar o efeito do etanol, do diabetes mellitus (DM) e da associação de ambos 
sobre os fetos de camundongo. Métodos: Foram utilizadas 24 fêmeas de camundongos Swiss divididas em 
quatro grupos de seis animais cada: controle (C); etanol (E); diabetes (D) (glicemia > 200 mg/dl), e diabetes 
+ etanol (DE). O diabetes foi induzido pela aloxana (40 mg/kg) no dia 7 da gestação. Os animais dos grupos 
E e DE receberam 4 g/kg de solução a 25% v/v de etanol intraperitoneal (IP), enquanto os animais dos 
grupos C e D receberam salina. No dia 18, todos os fetos foram coletados. Resultados: Foram encontradas 
as seguintes anomalias no grupo DE: exencefalia, situs inversus totalis, situs inversus partialis e apêndice 
cutâneo palpebral. Um animal do grupo E apresentou hipoplasia da artéria pulmonar. A administração 
de etanol reverteu parcialmente a reabsorção fetal induzida pelo diabetes, porém aumentou a morte fetal 
tardia. Ambos, diabetes e etanol, reduziram o diâmetro placentário e aumentaram o seu peso. O etanol teve 
mais efeito no comprimento de fetos machos, contudo isso não ocorreu com o diabetes. O etanol preveniu 
a redução da cauda induzida pelo diabetes em ambos os sexos. Conclusão: Esses resultados indicam que, 
embora o etanol possa melhorar o metabolismo energético no início da gestação, ele causa lesão celular 
que leva a defeitos cardiovasculares, dos membros e do tubo neural, além de morte fetal tardia e redução 
do tamanho da placenta.
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introduction
Major congenital anomalies are found in 2% to 3% 
of liveborn infants. The prevalence of such anomalies 
has been increasing in parallel with the decline in infant 
mortality rates, which is related to the number of diseases 
that are currently preventable. Among the congenital 
anomalies classified as isolated defects, those affecting the 
central nervous system are second only to cardiovascular 
anomalies(30).
Periconceptional folic acid supplementation has been 
shown to reduce significantly the first occurrence and 
recurrence of neural tube defects (NTDs) in humans, pointing 
to its role in the pathogenesis of this condition. However, 
in experimental animals, a variety of environmental agents 
have been implicated, including ethanol(10, 28), inhibition 
of cholesterol synthesis(6, 10), retinoic acid(45), vitamin A(23), 
hyperglycemia(12, 43), hypoxia(2, 13), ionizing radiation/
hyperthermia(30) and nicotine(18, 24).
It is well recognized that babies born to diabetic mothers 
are 3 to 4 times more prone to present congenital anomalies 
than is the general population(21, 34). Such anomalies have 
been correlated with inefficient blood glucose control(34, 
43) which may induce diabetic embryopathy, which 
encompasses NTDs and other system defects(12, 16).
Ethanol, which is widely consumed worldwide, has 
been implicated in the etiology of NTDs and of heart 
and craniofacial defects(27, 40). According to 1997 data 
provided by the United States Centers for Disease Control 
and Prevention(3), approximately 50% of all women of 
childbearing age drink alcoholic beverages. Additionally, 
60% of pregnant women may not realize they are pregnant 
until the fourth week of gestation(13, 28).
Animal models of ethanol-induced congenital 
anomalies have provided invaluable data regarding critical 
developmental periods and pathogenesis(37). Administering 
a dose of ethanol corresponding to the limit of human 
tolerance to C57B/6J mice during gastrulation has been 
shown to result in craniofacial defects, including midfacial 
hypoplasia and prosencephalic anomalies(38).
Recently, Padmanabhan and Shafiullah(28) demonstrated 
an increase in resorptions, intrauterine growth restriction 
and congenital anomalies in the litters of TO mice treated 
with streptozotocin-induced diabetes mellitus receiving a 
single dose of ethanol on gestational day 7 or 8.
The combination of experimental maternal diabetes 
mellitus and ethanol has received little attention. Therefore, 
it is important to determine how these two common 
environmental teratogenic factors interact. This approach 
is relevant since diabetes mellitus is quite common(15, 28) 
and ethanol is widely consumed by young women of 
reproductive age(5, 28).
Material and methods
This study was approved by the University of São 
Paulo Committee on Ethics in Animal Research (Process 
no 010/2004).
A total of 24 young nulliparous female Swiss mice 
weighing 40 to 50 g were used. The animals were housed 
in appropriate individual plastic cages in a 22oC, 12-h 
light/12-h dark environment and given ad libitum access 
to tap water and commercial mouse chow throughout the 
experiment.
Alloxan (40 mg/kg) was injected into the dorsal vein 
of the tail of 12 randomly-selected mice. The remaining 
12 mice received similar injections of saline. The diabetic 
mice were treated with subcutaneous injection of 0.25 IU 
of insulin (10 ml of Humulin® and 100 U/ml of neutral 
protamine hagedorn (NPH) human insulin; Eli Lilly, 
Indianapolis, IN, USA) until mating. Beginning at four 
days after the induction of diabetes, five females were 
caged together with 1 male for two hours daily, from 9:00 
to 11:00 am. Day 0 of pregnancy was determined by the 
presence of a vaginal plug. Pregnant mice were divided 
into four groups of 6 mice each: control (C); ethanol (E); 
diabetes (D) and diabetes plus ethanol (DE). Diabetic mice 
were considered those which presented blood glucose of 
over 200 mg/dl.
On day 7 of pregnancy, the mice in groups E and 
DE received an intraperitoneal injection of 25% ethanol 
(4 g/kg) in saline (v/v) and those in groups C and D received 
the same volume of saline.
Blood glucose from the tail was measured after a fasting 
time of 12 hours one day before treatment with alloxan or 
saline, three days after treatment and on the day of sacrifice 
using a MediSense Optium blood glucose meter (Abbott 
Laboratories, Abbott Park, IL, USA) and MediSense Optium 
blood glucose test strips (MediSense UK Ltd, Cambridge, 
England, UK).
On day 18 of pregnancy, the animals were killed in a 
CO2 chamber, and all fetuses were harvested by caesarean 
section. The fetuses were counted and the following data 
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were recorded: gender; body weight, crown-rump length 
and tail length. Placentas were also weighed and its 
diameter measured. Fetal weight and measurements were 
considered only for live fetuses. The number of resorptions 
(representing early fetal death), late fetal deaths (considered 
those fetuses that have completed their development and 
were in a process of degeneration), normal live fetuses 
and fetuses with NTD, as well as the total number of all 
anomalies, were recorded. Implants were defined as the 
sum of all resorptions, late fetal deaths and live fetuses 
with or without any anomaly. After fixation in buffered 
formalin, all fetuses were submitted to autopsy according 
to Sterz and Lehmann in situ sectioning method(35) using a 
stereomicroscope coupled to a digital camera.
All data were statistically analyzed using the GraphPad 
Prism 4.0 program for analysis of variance (ANOVA), the 
Kruskal-Wallis test, the Mann Whitney test and the Cytel 
StatXact® 7 program for the Fisher-Freeman-Halton test. 
Values of p < 0.05 were considered statistically significant.
Results
There was no difference in blood glucose level among 
the groups before treatment. After alloxan administration, 
however, blood sugar levels characteristic of diabetes were 
observed in groups D and DE (Figure 1).
Blood glucose level
Before treatment 3 days after treatment At sacrifice
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Figure 1 – Blood glucose level in mg/dl in the different groups and in different moments
There was no difference among the groups in terms of 
the number of implants. However, although the number of 
normal live fetuses did not differ between groups C (110) 
and E (94), there was a difference between these two groups 
and groups D and DE (Table 1).
Tabela 1
Number of implants, normal live fetuses, 
resorptions, live fetuses with congenital 
anomalies and late fetal death of groups C, 
e, D and De (Fisher-Freeman-Halton Test)
Findings
Groups (n = 6) p value
Control ethanol Diabetes
Diabetes 
+ ethanol
Implants 119 106 89 96 p = 0.049
Resorptions 8 9 19* 11 p = 0.002
Late fetal 
death
1 3 4 8* p = 0.002
Normal live 
fetuses
110 94 66* 65* p = 0.003
Live fetuses 
with 
congenital 
anomalies
0 1 0 12* p = 0.001
*Statistically different from control.
Resorption, the result of early fetal death, was 
significantly higher in group D animals, whereas late fetal 
death was higher in group DE ones (Table 1).
There were less normal live fetuses in groups D and 
DE and congenital anomalies were confined to groups DE 
and E, which received ethanol (Table 1). The congenital 
anomalies found were exencephaly (nine fetuses from group 
DE) (Figure 2A, Figure 2B is a control fetus), cutaneous 
tag over the eyelid (1 fetus from group DE) (Figures 3A 
and 3B), situs inversus totalis (Figures 4A and 4B) and situs 
inversus partialis (Figures 5A and 5B) (1fetus each from 
group DE) and pulmonary artery hypoplasia (one fetus from 
group E) (Figures 6A and 6B).
Figure 2 – Photograph of mouse fetuses. Neural tube defect is clearly seen in a group 
DE fetus (A). A normal control group fetus is shown in B
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Figure 6 – Photograph of the autopsy of a group E fetus. Note the severe hypoplasia of 
the pulmonary artery (PA) compared to the aorta in A. Histologic section at the level of 
the base of the heart depicts the hypoplastic pulmonary artery (PA) close to the normal 
sized aorta (Ao) in B (hematoxylin and eosin, 50x original magnification)
RA: right atrium, LA: left atrium.
Figure 3 – A cutaneous appendage on the right eyelid is seen in one fetus of group 
DE (A and B)
Figure 4 – Macroscopic pictures of the other anomalies found in a group DE fetus 
with situs inversus totalis. Note in A the apex of the heart turned to the right. After 
trimming off the lungs and displacement of the heart to the left, one can clearly see 
the aorta running along the right side of the vertebral column (arrow) in B. The tube 
running above the column is the esophagus (asterisk)
Figure 5 – A and B is from the autopsy of a group DE fetus with situs inversus par-
tialis. Note the right aortic arch (Ao) and descending aorta (Ao), dextrocardia and the 
normally positioned duodenum (Du) and stomach (S)
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A gender-based difference was found in terms of fetal 
length. Male crown-rump length was reduced in animals from 
groups E, D and DE, whereas female fetal crown-rump length 
was decreased only in groups D and DE. Male fetuses of group 
DE presented less crown-rump reduction than female ones and 
the most severely affected group of all was group D (Table 2).
Tabela 2
Median fetal crown-rump length of Swiss mouse fetuses recovered on gestational 
day 18 from dams which received saline (control), ethanol 4 mg/kg (ethanol), 
alloxan-induced diabetes + saline (diabetes) and alloxan-induced diabetes + ethanol 
4 mg/kg on gestational days 7, 8 and 9 (one way ANoVA, Kruskal-Wallis Test)
Control ethanol Diabetes Diabetes + ethanol
n n n n
Crown-rump length 
(male + female) (cm)
2.5 110 2.4 94 2 74 2.2 74
Male crown-rump 
length (cm)
2.5 56 2.4 49 2 38 2.2 29
Female crown-rump 
length (cm)
2.5 54 2.4 45 2 36 2.1 45
Dunns multiple comparison test for fetal crown-rump length
Male + female Male Female
Control vs. ethanol p < 0.05 p < 0.001 p > 0.05
Control vs. diabetes p < 0.001 p < 0.001 p < 0.001
Control vs. diabetes ethanol p > 0.05 p < 0.001 p < 0.001
Ethanol vs. diabetes p < 0.001 p < 0.001 p < 0.001
Ethanol vs. diabetes ethanol p > 0.05 p > 0.05 p < 0.01
Diabetes vs. diabetes ethanol p < 0.001 p > 0.05 p > 0.05
Fetal body weight was equally decreased in groups E, 
D and DE for both sexes and this finding correlated with 
IUGR (Table 3).
Tail length reduction was observed in both male 
and female fetuses from groups D and DE, although less 
intensely in the latter (Table 4).
Placental diameter was reduced in groups E, D and DE 
whereas placental weight was increased in groups E and 
DE (Table 5).
Discussion
The reproductive outcome is affected by different 
conditions that can be endogenous or exogenous. 
Maternal diabetes is a well known metabolic endogenous 
factor associated with poor pregnancy outcome, inducing 
congenital anomalies. Ethanol, on the other hand, is a 
common exogenous offender, recognized by its many 
deleterious actions on the developing fetus. When 
associated, diabetes and ethanol are expected do induce 
more harmful effects due to their synergistic action.
In the present study, Swiss mice became diabetic 
after alloxan administration before mating but were 
supplemented with insulin until they became pregnant. 
This approach was effective since we avoided any influence 
of alloxan on the fetuses at the same time fertility was kept 
unaltered with insulin treatment, which is reflected by the 
absent difference regarding implant number among all 
groups.
Although both ethanol and diabetes are detrimental to 
the fetuses, diabetes seems to be worse than ethanol on 
early fetal development due to the increased number of 
early fetal death observed in group D, whereas ethanol is 
worse on late fetal development, which is reflected by the 
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Tabela 3
Median fetal body weight and percentage of intrauterine growth restriction 
(iUGR) of Swiss mouse fetuses recovered on gestational day 18 from dams 
which received saline (control), ethanol 4 mg/kg (ethanol), alloxan-induced 
diabetes + saline (diabetes) and alloxan-induced diabetes + ethanol 4 mg/kg on 
gestational days 7, 8 and 9 (one way ANoVA, Kruskal-Wallis Test)
Control ethanol Diabetes Diabetes + ethanol
n n n n
Body weight (male + 
female) (g)
1.55 110 1.31 94 0.99 74 1.2 60
IUGR (male + female) -2 
SD (%)
1.82 110 13.8 94 68.9 74 43.3 60
Male weight (g) 1.59 56 1.27 49 1.08 38 1.22 29
IUGR (male) -2 SD (%) 1.75 56 40.8 49 74.5 38 68.9 29
Female crown-rump 
length (cm)
1.47 54 1.37 45 0.96 36 1.15 46
IUGR (female) -2 SD (%) 1.85 54 8.8 45 61.1 36 37.7 46
SD: standard deviation.
Dunns multiple comparison test for fetal crown-rump length
Male + female Male Female
Control vs. ethanol p < 0.001 p < 0.001 p < 0.01
Control vs diabetes p < 0.001 p < 0.001 p < 0.001
Control vs. diabetes ethanol p < 0.001 p < 0.001 p < 0.001
Ethanol vs. diabetes p < 0.001 p < 0.001 p < 0.001
Ethanol vs. diabetes ethanol p < 0.001 p < 0.001 p < 0.01
Diabetes vs. diabetes ethanol p > 0.05 p > 0.05 p > 0.05
increased late fetal death in group DE. It may be speculated 
that ethanol provides enhanced caloric availability in early 
gestation and thus prevents early fetal death. This may also 
be the explanation why IUGR, fetal body weight, crown-
rump length and tail length were less severely affected in 
group DE than in group D.
The mechanism involved in IUGR seen with both 
diabetes and ethanol is the production of reactive oxygen 
species and free radicals(28), which damage tissues, 
inducing apoptosis. It is postulated that the oxidative 
stress, possibly more intense with ethanol administration, 
may induce late fetal death and congenital anomalies. 
In fact, this was observed in the present study, since 
congenital anomalies were only observed in groups which 
received ethanol, either alone, group E or associated with 
diabetes, group DE, and late fetal death was higher in 
the latter. Additionally, cases of NTD were found only in 
the diabetic animals receiving ethanol, indicating that 
the combination of both factors is essential. This finding 
can be interpreted in the light of epidemiological studies 
which have found an increased risk for major systemic 
anomalies in human maternal diabetes without an overall 
incidence of anomalies, suggesting that diabetes is not 
a primary teratogen but acts by promoting an initial 
insult and potentializing the detrimental effects of other 
teratogens(22). The reverse has also been proposed, i.e., 
that ethanol potentiates the effects of diabetes or that 
anomalies are attributable to the interaction between 
ethanol and diabetes-induced metabolic disorders(19). 
Apoptosis and decreased migration and differentiation of 
neural crest cells(4) may be implicated in NTD. Therefore, 
the combination of the two teratogens would increase 
not only the risk of congenital anomalies but also that of 
intrauterine growth restriction (IUGR)(28).
PERES, L. C. et al. Effect of alloxan-induced diabetes mellitus and ethanol on pregnancy outcome in mice • J Bras Patol Med Lab •  v. 45 • n. 6 • p. 471-480 • dezembro 2009
477
Tabela 4
Median fetal tail length of Swiss mouse fetuses recovered on gestational day 18 
from dams which received saline (control), ethanol 4 mg/kg (ethanol), alloxan-
induced diabetes + saline (diabetes) and alloxan-induced diabetes + ethanol 
4 mg/kg on gestational days 7, 8 and 9 (one way ANoVA, Kruskal-Wallis Test)
Control ethanol Diabetes Diabetes + ethanol
n n n n
Tail length (male + 
female) (cm)
1.3 110 1.3 94 1.2 74 1.3 74
Male tail length (cm) 1.3 56 1.3 49 1.15 38 1.3 29
Female tail length 
(cm)
1.3 54 1.3 45 1.2 36 1.2 45
Dunns multiple comparison test for fetal tail length
Male + female Male Female
Control vs. ethanol p > 0.05 p > 0.05 p > 0.05
Control vs. diabetes p < 0.001 p < 0.001 p < 0.001
Control vs. diabetes ethanol p > 0.05 p > 0.05 p > 0.05
Ethanol vs. diabetes p < 0.001 p < 0.001 p < 0.001
Ethanol vs. diabetes ethanol p > 0.05 p > 0.05 p > 0.05
Diabetes vs. diabetes ethanol p < 0.001 p < 0.001 p < 0.05
Tabela 5
Median placental weight and median placental diameter of Swiss mouse fetuses recovered 
on gestational day 18 from dams which received saline (control), ethanol 4.0 mg/kg 
(ethanol), alloxan-induced diabetes + saline (diabetes) and alloxan-induced diabetes + 
ethanol 4 mg/kg on gestational days 7, 8 and 9 (one way ANoVA, Kruskal-Wallis Test)
Control ethanol Diabetes Diabetes + ethanol
n n n n
Placental 
weight (g)
0.107 110 0.12 94 0.11 74 0.111 74
Placental 
diameter (cm)
0.8 110 0.7 94 0.5 74 0.6 74
Dunns multiple comparison test for placental weight and diameter
Placental weight Placental diameter
Control vs. ethanol p < 0.001 p < 0.001
Control vs. diabetes p > 0.05 p < 0.001
Control vs. diabetes ethanol p < 0.01 p < 0.001
Ethanol vs. diabetes p > 0.05 p < 0.001
Ethanol vs. diabetes ethanol p > 0.05 p > 0.05
Diabetes vs. diabetes ethanol p > 0.05 p > 0.05
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Swiss mouse seems to be less affected by diabetes and/or 
ethanol than do other strains, such as TO(28) and C57BL/6J(39). 
The latter is particularly prone to the teratogenic effects of 
ethanol, resulting in the facial dysmorphisms seen in the 
fetal alcohol syndrome (FAS)(39), which were not found in 
the swiss mouse fetuses. However, it is not possible to assure 
that in the diabetic group not receiving ethanol there were 
no NTDs or other major defects.
One of the fetuses of group E presented pulmonary 
artery hypoplasia. This finding may be interpreted in the 
light of the studies that present congenital heart disease 
as part of FAS, what has already been demonstrated in 
animal models as well(5).
Situs inversus, totalis or partialis, a congenital defect 
characterized by the mirror image of viscera, is found 
in humans(32, 41) and animals(8, 42). This defect can be 
accompanied by other anomalies(20, 32) and is 84 times 
more common in infants born to diabetic women(14). Situs 
inversus is rare in mouse strains, including C57Bl/6J(25). 
Recently, a transgenic mouse strain (inv/inv mice) was 
reported, in which almost 100% of the homozygous 
individuals were characterized by situs inversus totalis as 
a consequence of insertional mutagenesis of the inversin 
gene(44). Therefore, the cases occurring in our study were 
probably related to diabetes although it is not possible 
to exclude any participation of the ethanol since it was 
found in group DE. In the same group, we found a case 
of a cutaneous appendage on the eyelid. No such defect 
has been reported previously, although there is evidence 
that ethanol interferes with ocular development, inducing 
anophthalmia, microphthalmia, hypo- and hypertelorism 
and cyclopia(33, 38).
IUGR was observed in all experimental groups, 
with increasing frequency in groups E, DE and D. The 
results of clinical studies have demonstrated that the 
development of embryos of diabetic mothers is impaired, 
and that growth restriction is a risk factor for congenital 
anomalies(29). Lin et al.(19) showed that rat infants born 
to diabetic dams receiving or not receiving ethanol 
weighed less than did those born to dams receiving 
ethanol or receiving no treatment. Although ours was 
a mouse model, this is in agreement with our findings. 
Those authors stated that fetal growth is accelerated after 
gestational day 11 in the rat, and that using a single dose 
prior to that moment, as was done in the present study, 
would therefore have a less intense effect at the end of 
gestation. In addition, Padmanabhan and Shafiullah(28) 
showed that the IUGR induced by ethanol injection on 
gestational day 8 in a mouse model of diabetes was less 
intense than that caused by ethanol injection on day 7, 
indicating that the effect is gestational stage-dependent.
In group E, fetal weight of male and female fetuses 
was lower than that seen in group C. This finding is 
in accordance with those previously described(11, 36). 
Diabetes also induced IUGR that was more pronounced 
than that induced by ethanol.
We found that diabetes impaired tail growth, 
although the same was not found for ethanol. Once 
again, ethanol was found to block further reductions 
in tail length in male and female infant mice born to 
diabetic dams, possibly because of the higher calorie 
provided by ethanol.
Although the combination of ethanol and diabetes 
induced less IUGR and tail growth, it was the cause of 
the NTDs and other major anomalies seen. Therefore, 
the net result is decidedly negative.
Contrary to diabetes, which affects both genders in 
a similar way, ethanol affects male fetuses crown-rump 
length more intensely than female ones.
The influence of ethanol alone or in association with 
diabetes on the placenta was more marked, resulting in 
a heavier placenta. The correlation between IUGR and 
loss of placental size might constitute a cause and effect 
relationship or might be the net result of the deleterious 
effects that both diabetes and ethanol have on the fetuses 
and placentas simultaneously. In humans, the placenta 
is usually larger and heavier in diabetic women, possibly 
related to the chronically reduced blood flow(17) caused 
by diabetes-induced systemic hypertension, which in 
turn might be linked to the diabetic embryopathy(31). 
Although we have not tested this hypothesis, it is possible 
that an abnormal uterine environment is the cause of the 
placental size reduction seen in our animals.
The perinatal deaths observed in the present study 
indicate placental insufficiency, since the apparent cause 
was asphyxia, as it typically is in humans(9). In a rat model 
of preeclampsia, diabetes-induced oxidative stress was 
the cause of the placental insufficiency(26). Akay and 
Koçkaya(1) showed that fibrin deposition, inflammation, 
fibroblast proliferation and synthesis of the extracellular 
matrix in the placentas of rats exposed to ethanol, that 
could explain the weight increase in groups E and DE 
placentas, together with the diabetes-related impairment 
of the influx of nutrients from the maternal circulation(7), 
contribute to IUGR and late fetal death. These findings 
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explain at least in part the larger number of perinatal 
deaths observed in the diabetic groups, all of which 
presented reduction of placental size.
In summary, the present study shows that, although 
a single high dose of ethanol administered to Swiss mice 
with alloxan-induced diabetes mellitus on gestational day 
7 has some favorable effects in terms of less IUGR and tail 
reduction, it induces congenital anomalies, cardiovascular 
defects and NTDs in particular, reduction of the size 
and increase in the weight of the placenta and late fetal 
death. The synergism of the two teratogenic factors is a 
relevant issue and, despite interspecies differences, can 
serve as a warning of the risk that this combination poses 
to human population.
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